Display options
Share it on

Endosc Ultrasound. 2019 Jan-Feb;8(1):31-35. doi: 10.4103/eus.eus_29_17.

A novel, stepwise approach combining conventional and endobronchial ultrasound needle aspiration for mediastinal lymph node sampling.

Endoscopic ultrasound

Levy Liran, Kuint Rottem, Fridlender Zvi Gregorio, Abutbul Avi, Berkman Neville

Affiliations

  1. Institute of Pulmonary Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.

PMID: 28879863 PMCID: PMC6400088 DOI: 10.4103/eus.eus_29_17

Abstract

BACKGROUND AND OBJECTIVES: Since the introduction of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), most pulmonary centers use this technique exclusively for mediastinal lymph node (LN) sampling. Conventional "blind" TBNA (cTBNA), however, is cheaper, more accessible, provides more tissue, and requires less training. We evaluated whether sampling of mediastinal LN using EBUS-TBNA or cTBNA according to a predefined set of criteria provides acceptable diagnostic yield.

MATERIALS AND METHODS: Sampling method was determined prospectively according to a predefined set of criteria based on LN station, LN size, and presumed diagnosis. Sensitivity, specificity, positive, and negative predictive value were evaluated for each modality.

RESULTS: One hundred and eighty-six biopsies were carried out over a 3-year period (86 cTBNA, 100 EBUS-TBNA). Seventy-seven percent of LN biopsied by EBUS-TBNA were <20 mm, while 83% of cTBNA biopsies were ≥20 mm. Most common sites of cTBNA sampling were station 7, 4R, and 11R as opposed to 7, 11R, 4R, and 4 L in the case of EBUS-TBNA. Most common EBUS-TBNA diagnosis was malignancy versus sarcoidosis in cTBNA. EBUS-TBNA and cTBNA both had a true positive yield of 65%, but EBUS-TBNA had a higher true negative rate (21% vs. 2% for cTBNA) and a lower false negative rate (7% vs. 28%). Sensitivity, specificity, positive predictive value, and negative predictive value for EBUS-TBNA were 90%, 100%, 100%, and 75%, respectively, and for cTBNA were 68%, 100%, 100%, and 7%, respectively.

CONCLUSION: A.

stepwise approach based on LN size, station, and presumed diagnosis may be a reasonable, cost-effective approach in choosing between cTBNA and EBUS-TBNA.

Keywords: Biopsy; conventional transbronchial needle aspiration; endobronchial ultrasound-guided transbronchial needle aspiration; lung cancer; lymphadenopathy

Conflict of interest statement

None

References

  1. Chest. 2003 Jan;123(1 Suppl):157S-166S - PubMed
  2. Chest. 2003 Feb;123(2):604-7 - PubMed
  3. Sarcoidosis Vasc Diffuse Lung Dis. 2004 Jun;21(2):147-51 - PubMed
  4. Chest. 2006 Sep;130(3):710-8 - PubMed
  5. Eur Respir J. 2007 Jun;29(6):1182-6 - PubMed
  6. Am J Clin Pathol. 2007 Sep;128(3):474-80 - PubMed
  7. Thorax. 2008 Apr;63(4):360-5 - PubMed
  8. Respirology. 2007 Nov;12(6):863-8 - PubMed
  9. Eur Respir J. 2009 May;33(5):1156-64 - PubMed
  10. Thorax. 2009 Sep;64(9):757-62 - PubMed
  11. Respiration. 2010;79(6):482-9 - PubMed
  12. Postgrad Med J. 2010 Feb;86(1012):106-15 - PubMed
  13. J Thorac Oncol. 2010 Jun;5(6):804-9 - PubMed
  14. Tuberk Toraks. 2011;59(2):153-7 - PubMed
  15. Thorax. 2011 Nov;66 Suppl 3:iii1-21 - PubMed
  16. J Bronchology Interv Pulmonol. 2010 Jul;17(3):223-7 - PubMed
  17. Am J Respir Crit Care Med. 2013 Nov 15;188(10):1216-23 - PubMed
  18. Ann Am Thorac Soc. 2013 Dec;10(6):685-9 - PubMed
  19. Mol Clin Oncol. 2014 Jan;2(1):151-155 - PubMed
  20. Expert Rev Respir Med. 2014 Dec;8(6):763-76 - PubMed
  21. Respiration. 2014;88(6):478-83 - PubMed
  22. Respirology. 2015 Feb;20(2):333-9 - PubMed
  23. Respir Investig. 2016 Jul;54(4):230-6 - PubMed
  24. Chest. 1994 Sep;106(3):709-11 - PubMed

Publication Types